PASW:NASDAQPing An Biomedical Co., Ltd. analysis
Data as of Oct 20, 2026 - not real-time
- Latest price
- $0.12
- Risk: high
- 9/10High risk
Summary
At $0.1249, Ping An Biomedical Co., Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have gained 1.5%. Relative strength is 48.7 — neutral — and the MACD signal is bullish. Watch $0.1080 as support and $0.1370 as the nearer resistance level.
Revenue is contracting at 47.4% on a -14.8% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 78.8%, a beta of 1.15 and a maximum drawdown of 84.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 4/10.
Revenue is contracting at 47.4% on a -14.8% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 78.8%, a beta of 1.15 and a maximum drawdown of 84.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 4/10.
Top market events
- HONG KONG, July 22, 2026 GLOBE NEWSWIRE -- Ping An Biomedical Co.
- HONG KONG, July 22, 2026 GLOBE NEWSWIRE -- Ping An Biomedical Co.
- Investing11dPing An Biomedical Co Ltd PASW The Ping An Biomedical EPS TTM is -0.
Market outlook
Short term
< 1 yearCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.16
- MACD momentum is positive
Medium term
1–3 yearsCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.16
- 30-day volatility of 78.8%
Long term
> 3 yearsCautious
Model confidence4/104 out of 10
Key factors
- Negative profit margin of -14.8%
- Negative return on equity of -11.4%
- Revenue contracting at -47.4%
Key metrics
Financial health
Revenue Growth-47.40%
Profit Margin-14.78%
ROE-11.35%
ROA-8.86%
Debt/Equity13.14
P/B Ratio1.3
Op. Cash Flow$-5542738
Free Cash Flow$-46387028
Technical analysis
TrendBearish
RSI48.7
Support$0.11
Resistance$0.14
MA 20$0.12
MA 50$0.13
MA 200$0.16
MACDBullish
VolumeIncreasing
Fear & Greed Index90.41
Valuation
GradeFair
TypeBlend
Risk assessment
Beta1.15
Volatility78.81%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.